CL's Q2 results are likely to reflect benefits from pricing, innovation and gross margin gains amid inflation and foreign exchange headwinds.

The headline numbers for Tradeweb (TW) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

EWU offers a compelling relative value versus SPY, with attractive valuation, higher dividend yield, and other relatively strong features versus the S&P 500. The UK market, via EWU, is less exposed to tech concentration risk than the S&P 500, making it a useful hedge in uncertain times. Currency trends and global macro shifts could favor non-US equities like EWU over the next 3-5 years, especially if the US dollar weakens.

Insider buying activity stands out against broader market trends, with significant purchases by leadership even as consensus sentiment and EPS revisions remain negative. I believe these purchases signal potential confidence in future EPS recovery and dividend sustainability. Even after the recent payout cut, ABR offers a forward dividend yield above 10%.

The Justice Department is dropping its case against Fat Brands and Andy Wiederhorn, the restaurant operator's chair. More than a year ago, the company and Wiederhorn were indicted for an alleged "sham" loan scheme.

ALKS beats second-quarter estimates as proprietary product sales rise 14% y/y, offsetting weaker manufacturing and royalty revenues.

Both ADP jobs and Q2 GDP outperformed estimates this morning. The FOMC meeting concludes later today.

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Novo Nordisk A/S (NYSE: NVO) resulting from allegations that Novo Nordisk may have issued materially misleading business information to the investing public. So What: If you purchased Novo Nordisk securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangem.

SAN DIEGO , July 30, 2025 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Capricor Therapeutics, Inc. (NASDAQ: CAPR) securities between October 9, 2024 and July 10, 2025. Capricor is a clinical-stage biotechnology company that engages in the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.

SMR holds a regulatory and commercial edge, but OKLO's stock has soared 701.5% despite being pre-revenue and unlicensed.

GNRC second-quarter earnings beat estimates with 6% revenue growth and gains across Residential and C&I segments.

AEP posts an 11.7% Q2 earnings beat and 11.1% revenue growth, driven by strong performance across all core segments.

Ternium S.A. (NYSE:TX ) Q2 2025 Earnings Conference Call July 30, 2025 8:30 AM ET Company Participants Maximo Vedoya - Chief Executive Officer Pablo Daniel Brizzio - Chief Financial Officer Sebastián Martí - Investor Relations Director Conference Call Participants Caio Greiner - UBS Investment Bank, Research Division Carlos De Alba - Morgan Stanley, Research Division Rafael Barcellos - Banco Bradesco BBI S.A.

AUBURN HILLS, Mich. , July 30, 2025 /PRNewswire/ -- BorgWarner has been awarded a place on the Forbes list of America's Best Employers for Women 2025 for the second consecutive year.

Americans are buying fewer Oreo cookies and other snacks, Mondelez said Tuesday. Shoppers' worries about the economy are a major reason.

Tesla Inc. TSLA has been riding through a rough patch. Between Elon Musk's growing list of distractions, intensifying Chinese EV competition, a public feud with President Donald Trump, and a steep drop in global EV demand, the company has watched its sales shrink and its stock underperform the broader tech rally.

HSBC Holdings PLC (LSE:HSBA) shares neared the session close down 2.3% at 943.5p after a volatile session, but recovered some earlier losses as investors digested the latest quarterly update. UBS described the results as better than expected beneath the surface, with adjusted pre-tax profit 10% above consensus when excluding a hefty $2.1 billion writedown on HSBC's stake in China's Bank of Communications (BoCom) and higher restructuring costs.

ALVO preps for Q2 results as investors eye early U.S. traction for Simlandi and Selarsdi, plus pipeline progress.

ESS tops Q2 estimates with higher core FFO and revenues and lifts full-year 2025 outlook amid solid same-property growth.

ATLANTA , July 30, 2025 /PRNewswire/ -- Peach State Health Plan ("PSHP"), a leading managed care organization in Georgia and a company of Centene Corporation (NYSE: CNC) ("Centene"), continues to deepen its collaboration with the Barrow County School System through community-focused initiatives that prioritize student wellness, academic readiness, and family support. Following the success of the Barrow Together CommUNITY Fest in May 2025, PSHP partnered once again with Barrow County Schools to support the annual Back-to-BOLD back-to-school event held on July 25, 2025.